22 May 2013
Keywords: viropharma, slumps, ahead, fda, meeting, shares, plummeted
Article | 25 March 2002
Shares of ViroPharma plummeted 18% to $14.30 after a research note fromFulcrum Global Partners said that the firm is unlikely to get ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 March 2002
21 May 2013
© 2013 thepharmaletter.com